Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection

dc.contributor.authorCheng, Yao-Wen
dc.contributor.authorPhelps, Emmalee
dc.contributor.authorNemes, Sara
dc.contributor.authorRogers, Nicholas
dc.contributor.authorSagi, Sashidhar
dc.contributor.authorBohm, Matthew
dc.contributor.authorEl-Halabi, Mustapha
dc.contributor.authorAllegretti, Jessica R.
dc.contributor.authorKassam, Zain
dc.contributor.authorXu, Huiping
dc.contributor.authorFischer, Monika
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2020-04-23T19:15:52Z
dc.date.available2020-04-23T19:15:52Z
dc.date.issued2020
dc.description.abstractBackground & Aims Fecal microbiota transplantation (FMT) is recommended for recurrent Clostridioides difficile infection (CDI). FMT cures nearly 80% of patients with severe or fulminant CDI (SFCDI) when utilized in a sequential manner. We compared outcomes of hospitalized patients before and after implementation of an FMT program for SFCDI and investigated whether the changes could be directly attributed to the FMT program. Methods We performed a retrospective analysis of characteristics and outcomes of patients hospitalized for SFCDI (430 hospitalizations) at a single center, from January 2009 through December 2016. We performed subgroup analyses of 199 patients with fulminant CDI and 110 patients with refractory SFCDI (no improvement after 5 or more days of maximal anti-CDI antibiotic therapy). We compared CDI-related mortality within 30 days of hospitalization, CDI-related colectomy, length of hospital stay, and readmission to the hospital within 30 days before (2009–2012) vs after (2013–2016) implementation of the inpatient FMT program. Results CDI-related mortality and colectomy were lower after implementation of the FMT program. Overall, CDI-related mortality was 10.2% before the FMT program was implemented vs 4.4% after (P = .02). For patients with fulminant CDI, CDI-related mortality was 21.3% before the FMT program was implemented vs 9.1% after (P = .015). For patients with refractory SFCDI, CDI-related mortality was 43.2% before the FMT program vs 12.1% after (P < .001). The FMT program significantly reduced CDI-related colectomy in patients with SFCDI (6.8% before vs 2.7% after; P = .041), in patients with fulminant CDI (15.7% before vs 5.5% after; P = .017), and patients with refractory SFCDI (31.8% vs 7.6%; P = .001). The effect of FMT program implementation on CDI-related mortality remained significant for patients with refractory SFCDI after we accounted for the underlying secular trend (odds ratio, 0.09 for level change; P = .023). Conclusions An FMT program significantly decreased CDI-related mortality among patients hospitalized with refractory SFCDI.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationCheng, Y. W., Phelps, E., Nemes, S., Rogers, N., Sagi, S., Bohm, M., ... & Fischer, M. (2020). Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2019.12.029en_US
dc.identifier.urihttps://hdl.handle.net/1805/22620
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.cgh.2019.12.029en_US
dc.relation.journalClinical Gastroenterology and Hepatologyen_US
dc.rightsPublisher Policyen_US
dc.sourcePublisheren_US
dc.subjectgut microbeen_US
dc.subjectdysbiosisen_US
dc.subjectbacteriaen_US
dc.titleFecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infectionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Cheng_2020_fecal.pdf
Size:
817.69 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: